Volume 5, Issue 2, June 2020, Page: 26-33
Development and Validation of HPLC assay of Lycopene in Different Matrices
Muhammad Amjad, Department of Chemistry, Lahore Garrison University, Lahore, Pakistan
Shabbir Hussain, Department of Chemistry, Lahore Garrison University, Lahore, Pakistan
Abdul Rehman Khan, Department of Chemistry, Lahore Garrison University, Lahore, Pakistan
Received: May 11, 2020;       Accepted: May 29, 2020;       Published: Jul. 13, 2020
DOI: 10.11648/j.wjac.20200502.13      View  53      Downloads  33
Abstract
Lycopene is the red pigment richly found in many red -colored fruits and vegetables such as tomatoes, papaya, pink grapefruit, pink guava, and watermelon. It is an antioxidant that has various beneficent effects and protects against oxidative damage to lipids, protein, and DNA. It is a potent quencher of oxygen and most effective against cancer, cardiovascular diseases, osteoporosis, hypertension, male infertility, and neurodegenerative disease. Lycopene is synthesized by plants and microorganisms but not animals and humans. The main objective of this study is to develop and validate an HPLC assay method for the determination of lycopene in tomato, watermelon, and human blood. A simple assay method is an economical assay method, suitable for the determination of lycopene from plant and biological sources. A new accurate, specific, precise, high performance liquid chromatographic (HPLC) method has been developed and validated for the determination of lycopene in tomatoes, watermelon and blood sample according to the International Conference on Harmonization (ICH) guidelines. Acetonitrile, Methanol, Water (65%, 20%, and 15%) was used as the mobile phase at a flow rate of 0.7ml/min. using a symmetry C18 column. The effluent was spectrophotometrically monitored at 484nm. The calibration curve was linear with a correlation coefficient of 0.9994. The average recovery was found to be 102.0%. The proposed HPLC method was successfully applied to quantify the amount of lycopene in different matrices.
Keywords
HPLC, Lycopene, C18, Correlation Coefficient, Validation
To cite this article
Muhammad Amjad, Shabbir Hussain, Abdul Rehman Khan, Development and Validation of HPLC assay of Lycopene in Different Matrices, World Journal of Applied Chemistry. Vol. 5, No. 2, 2020, pp. 26-33. doi: 10.11648/j.wjac.20200502.13
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Rao A. V., Agarwal, S.: Role of antioxidant lycopene in cancer and heart disease. J Am College of Knut, 19 (5): 563-569, 2000.
[2]
Agarwal, S., Rao, A. V.: Tomato lycopene and its role in human health and chronic diseases. Cana-dian Medical Association Journal, 739-44, 2000.
[3]
Stahl, W., Schwarz, W., Sundquist, A. R., Sies, H.: Cis-trans Isomers of lycopene and b-carotene in human serum and tissues. Arch Biochem Biophys, 294: 173-177, 1992.
[4]
Rao, A. V., Agarwal, S.: Effect of diet and smoking on serum lycopene and lipid eroxidation. Nutr Res, 18: 713-721, 1998.
[5]
Khachik, F., Carvallo, L., Bernstein, P. S., Muir, G. J., Zhao, D. Y., Katz, N. B.: Chemistry, distribution and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood), 227: 845-851, 2002.
[6]
Rao, A. V., Agarwal, S.: Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review. Nutr Res 19: 305-323, 1999.
[7]
Giovannocci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Willet, W. C.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J National Cancer Institute 87: 1767-1776, 1995.
[8]
LaVecchia, C.: Mediterranean epidemiological evidence on tomatoes and the prevention of digestivetract cancers. Proc Soc Exp Bio Med, 218: 125-128, 1997.
[9]
Dorgan, J. F., Sowell, A., Swanson, C. A., et al.: Relationship of serum carotenoids, retinol, a-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control, 9: 89-97, 1998.
[10]
Gann, P., Ma, J., Giovannucci, E., Willett, W., Sacks, F. M., Hennekens, C. H.: Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res, 59: 1225-1230, 1999.
[11]
Paran, E., Engelhard, Y.: Effect of Lyc-O-Mato, standardized tomato extract on blood pressure, serum lipoproteins, plasma homocysteine and oxidative stress markers in grade 1 hypertensive patients. Proceedings of the 16th Annual Scientific Meeting of the Society of Hypertension, San Francisco, USA, 2001.
[12]
Kim, L., Rao, A. V., LG, R.: Effect of lycopene on Prostate LNCaP Cancer Cells in Culture. Journal of Medicinal Food, 5 (4): 181-187, 2002.
[13]
Bowen, P., Chen, L., Stacewicz-Sapuntzakis, M., et al.: Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med (Maywood), 227 (10): 886-893, 2002.
[14]
Kucuk, O., Wood, D. P. Jr.: Response of hormone refractory prostate cancer to lycopene. J Urol, 167: 651, 2002.
[15]
Parthasarathy, S., Steinberg, D., Witztum, J. L.: The role of oxidized low-density lipoproteins in pathogenesis of atherosclerosis. Ann Rev Med, 43: 219-225, 1992.
[16]
Rao, A. V.: Lycopene, tomatoes and the prevention of coronary heart disease. Exp Bio Med, 227: 908-913, 1992.
[17]
Rao, V., Heber, D.: Future directions and intake recommendations. Scotland U. K.: Caledonian Sci-ence Press, 2001.
[18]
Chambless, L. L., Keil, U., Dobson, A., et al.: Population versus clinical view of case fatality from acute coronary heart disease. Results from the WHO MONICA project. 1985-1990. Circulation, 96: 3849-3859, 1997.
[19]
Gianetti, J., Pedrinelli, R., Petrucci, R., et al.: Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J, 143 (3): 467-74, 2002.
[20]
Iribarren, C., Folsom, A. R., Jacobs, D. R.: Association of serum vitamin levels, LDL susceptibility to oxidation, and sutoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol, 17: 1171-1177, 1997.
[21]
Rissanen, T., Vontilainen, S., Nyyssonen, K., Salonen, R., Salonen, J. T.: Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid artery wall. Arteriocler Thromb Vasc Biol, 20: 2677-2687, 2000.
[22]
Kohlmeier, L., Kark, J. D., Gomez-Garcia, E., et al.: Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol, 146: 618-626, 1997.
[23]
Gomez-Aracena, J., Sloots, J., Garcia-Rodriguez, A. et al.: Antioxidants in adipose tissue and myo-cardial infarction in Mediterranean area. The EURAMIC study in Malaga. Nutr Metab Cardiovasc Dis, 7: 376-382, 1997.
[24]
Fuhramn, B., Elis, A., Aviram, M.: Hypocholesterolemic effect of lycopene and b-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophage. Biochem Biophys Res Commun, 233: 658-662, 1997.
[25]
Rao, A. V., Agarwal, S.: Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Canc, 31: 199-203, 1998.
[26]
Morton, D. J., Barrett-Connor, E. L., Schneider, D. L.: Vitamin C supplement and bone mineral density in postmenopausal women. J Bon Min Res, 16: 135-140, 2001.
[27]
Singh, V. N.: A current perspective on nutrition and exercise. J Nutr, 122: 760-765, 1992.
[28]
Ishimi, Y., Ohmura, M., Wang, X., Yamaguchi, M., Ikegami, S.: Inhibition by carotenoids and retinoic acid of osteoclast-like cell formation induced by bone-resorbing agents in vitro. J Clin Biochem Nutr, 27: 113-122, 1999.
[29]
Rao, L. G., Krishnadev, N., Banasikowska, K., Rao, A. V.: Lycopene I - Effect on osteoclasts: Lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption medi-ated by reactive oxygen species in rat bone marrow cultures. J Med Food, 6 (2): 69-78, 2003.
[30]
Kim, L., Rao, A. V., Rao, L. G.: Lycopene II - Effect on osteoblasts: The caroteroid lycopene stimulates cell proliferation and alkaline phosphatase activity of SaOS-2 cells. J Med Food, 6 (2): 79-86, 2003.
[31]
Park, C. K., Ishimi, Y., Ohmura, M., Yamaguchi, M., Ikegami, S.: Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells. J Nutr Sci Vitaminol, 43: 281-296, 1997.
[32]
Iwasaki, A., Gagnon, C.: Formation of reactive oxygen species in spermatozoa of infertile patients. Fertil Steril, 57: 409-416, 1992.
[33]
Zini, A., de Lamirande, E., Gagnon, C.: Reactive oxygen species in semen of infertile patients: levels of superoxide dismutase and catalase-like activities in seminal plasma and spermatozoa. Int J Androl, 16: 183-188, 1993.
[34]
Geva, E., Bartoov, B., Zabludovsky, N., Lessing, J. B., Lerner-Geva, L., Amit, A.: The effect of antioxi-dant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril, 66: 4320-4434, 1996.
[35]
Kessopoulou, E., Powers, H. J., Sharma, K. K., et al.: A double-blind randomized placebo crossover-controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril, 64: 825-831, 1995.
[36]
Suleiman, S. A., Ali, M. E., Zaki, Z. M., el-Malik, E. M., Nasr, M. A.: Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl, 17: 530-537, 1996.
[37]
Palan, P., Naz, R.: Changes in various antioxidant levels in human seminal plasma related to immunofertility. Arch Androl, 36: 139-143, 1996.
[38]
Mohanty, N. K., Kumar, R., Gupta, N. P.: Lycopene therapy in the management of idiopathic oligoasthenospermia. Ind J Urol, 56: 102-103, 2001.
[39]
Halliwell, B.: Oxidants and the central nervous system: some fundamental questions. Acta Neurologica Scandinavica, 126: 23-33, 1989.
[40]
Rao, A. V., Balachandran, B.: Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutritional Neurosciences, 5 (5): 291-309, 2003.
[41]
Schmidt, R., Fazekas, F., Hayn, M., et al.: Risk factors for microangiopathy-related cerebral damage in Aistrian stroke prevention study. J Neurol Sci, 152: 15-21, 1997.
[42]
Snowdon, D. A., Gross, M. D., Butler, S. M.: Antioxidants and reduced functional capacity in the elderly: finding from the Nun study. J Gerontology Series A - Biological Sciences and Medical Sciences, 51: M10-M16, 1996.
[43]
Ascherio et al 1992 Ascherio, A., Stampfer, M. J., Colditz, G. A., Rimm, E. B., Litin, L. & Willett, W. C. (1992) Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J. Nutr. 122: 1792–1801.
[44]
Block et al 1986 Block, G., Hartman, A. M., Dresser, C. M., Carroll, M. D., Gannon, J. & Gardner, L. (1986) A data-based approach to diet questionnaire design and testing. Am. J. Epidemiol. 124: 453–469.
[45]
Brady et al 1996 Brady, W. E., Mares-Perlman, J. A., Bowen, P. & Stacewicz-Sapuntzakis, M. (1996) Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J. Nutr. 126: 129–137.
[46]
Buiatti et al 1996 Buiatti, E., Munoz, N., Kato, I., Vivas, J., Muggli, R., Plummer, M., Benz, M., Franceschi, S. & Oliver, W. (1996) Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer. Int. J. Cancer. 65: 317–322.
[47]
Campbell et al 1994 Campbell, D. R., Gross, M. D., Martini, M. C., Grandits, G. A., Slavin, J. L. & Potter, J. D. (1994) Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol. Biomarkers Prev. 3: 493–500.
[48]
National Center for Health Statistics 1996 National Center for Health Statistics (1996) Associations of plasma carotenes.
Browse journals by subject